MOLECULAR TUMOR BOARD
GenomOncology’s Molecular Tumor Board enables clinicians to make treatment decisions through a fully integrated workflow that provides alteration-specific content matched to the patient's molecular and clinical history. Clinicians can create, edit and present cases during a Molecular Tumor Board meeting, creating a final report to include in a patient's EHR record. The GenomOncology Molecular Tumor Board is a streamlined tool that automates your Tumor Board process and provides relevant, meaningful content to inform a patient's treatment plan.
Experience the power of our robust point-of-care solution at your next Tumor Board.
WHAT WE ENABLE YOU TO DO
Our tool compiles in-depth variant information from a number of different databases using our complex biomarker ontology to help you assess the significance of variants all in one view
​
Variant Information
Our sophisticated match results are based on the patient's molecular variant data coupled with clinical data to provide highly relevant recommendations.
​
​
Match Results
With our solution, you have access to Vanderbilt University's My Cancer Genome's curation of every biomarker-driven trial at the eligibility criteria level
Curated Clinical Trial Eligibilities
Investigate Recommendations
Our Molecular Tumor Board enables you to review trials through curated eligibilities and significant match details for quick verification of trial recommendations
​
Separation of
Institutional Trials
Our tool enables you to view and prioritize clinical trials offered at your institution separately from trials available at other institutions by integrating with your clinical trial management system
​
Wild-type Match and Partial Match
We provide you with additional trials that match to a patient due to the absence of tested alterations and trials that the patient would be eligible for if variants had been tested for
AUTOMATING YOUR WORKFLOW
CLINICAL DATA
Our tool easily integrates with your clinical data warehouse to extract all relevant case-level, non-molecular information. We can combine this information with molecular data to automatically create cases that can be easily analyzed and reviewed.
MOLECULAR DATA
Our tool can also automatically generate cases upon receiving new files from vendors through Secure File Transfer Protocol (SFTP). It differentiates between vendors and assays for comprehensive variant processing.
FINAL RECOMMENDATIONS
Our solution enables you to capture case-level recommendations to be able to export or send out to EHR systems. Our flexible reporting tools enable you to create case summaries, meeting summaries, and Molecular Tumor Board presentations.
